The FDA has approved eltrombopag (Promacta), by GlaxoSmithkline for use in patients withHepatitis C and thrombocytopenia.  The drugwill be usedto increase platelet counts so patients can receive interferon-basedtreatment.  What are the current treatment options for hepatitis C?

 

For more Information, please see the article in REUTERS.

“Image courtesy of [rajcreationzs]/ FreeDigitalPhotos.net

Advertisements